Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine
Abstract We developed a virus-like particle (VLP)-based therapeutic vaccine against angiotensin II receptor type 1, ATR-AP205-001, which could significantly reduce the blood pressure and protect target organs of hypertensive animals. In this study, we focused on the immunological effect and safety o...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2017-10-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-017-12996-y |